DAG1 and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan: Defects in dystroglycan glycosylation are associated with a group of muscular dystrophies, termed dystroglycanopathies, that include Fukuyama congenital muscular dystrophy (FCMD).